-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 3, the new drug category 2.
Figure 1: Healthyuan’s application status of aclidinium bromide inhalation powder
Source: CDE official website
Table 1: The status of key inhalant products declared by Joincare and its subsidiaries earlier
Source: Meinenet MED2.
According to data from Meinenet.
Figure 2: The latest clinical situation of some new inhalation drugs of Health Yuan
Source: China Drug Clinical Trial Publicity Library of Meinenet
Among the 9 clinically approved inhalation products, 4 are registered as new drugs.
In addition, the clinical application of category 3 imitation of mometasone formoterol inhalation aerosol is under review and approval.
At present, Joincare’s inhalation product line continues to have new products entering the clinical and market stage.
Source: CDE official website, Minet database
The review data statistics are as of April 6.